Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming

BACKGROUND: Cancer immunotherapies are generally effective in patients whose tumors contain a priori primed T-cells reactive to tumor antigens (TA). One approach to prime TA-reactive T-cells is to administer immunostimulatory molecules, cells, or pathogens directly to the tumor site, that is, in sit...

Descripción completa

Detalles Bibliográficos
Autores principales: Aleynick, Mark, Svensson-Arvelund, Judit, Pantsulaia, Gvantsa, Kim, Kristy, Rose, Samuel A, Upadhyay, Ranjan, Yellin, Michael, Marsh, Henry, Oreper, Daniel, Jhunjhunwala, Suchit, Moussion, Christine Carine, Merad, Miriam, Brown, Brian D, Brody, Joshua D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373699/
https://www.ncbi.nlm.nih.gov/pubmed/37487664
http://dx.doi.org/10.1136/jitc-2023-007198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373699/
https://www.ncbi.nlm.nih.gov/pubmed/37487664
http://dx.doi.org/10.1136/jitc-2023-007198

Ejemplares similares